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Summary
 
Recruitment of leukocytes from blood to tissue in inflammation requires the function of spe-
cific cell surface adhesion molecules. The objective of this study was to identify adhesion mol-
ecules that are involved in polymorphonuclear leukocyte (PMN) locomotion in extravascular
tissue in vivo. Extravasation and interstitial tissue migration of PMNs was induced in the rat
mesentery by chemotactic stimulation with platelet-activating factor (PAF; 10
 
2
 
7
 
 M). Intravital
time-lapse videomicroscopy was used to analyze migration velocity of the activated PMNs, and
the modulatory influence on locomotion of locally administered antibodies or peptides recog-
nizing various integrin molecules was examined. Immunofluorescence flow cytometry revealed
increased expression of 
 
a
 
4
 
, 
 
b
 
1
 
, and 
 
b
 
2
 
 integrins on extravasated PMNs compared with blood
PMNs. Median migration velocity in response to PAF stimulation was 15.5 
 
6
 
 4.5 
 
m
 
m/min
(mean 
 
6
 
 SD). Marked reduction (67 
 
6
 
 7%) in motility was observed after treatment with
mAb blocking 
 
b
 
1
 
 integrin function (VLA integrins), whereas there was little, although signifi-
cant, reduction (22 
 
6
 
 13%) with 
 
b
 
2
 
 integrin mAb. Antibodies or integrin-binding peptides
recognizing 
 
a
 
4
 
b
 
1
 
, 
 
a
 
5
 
b
 
1
 
, or 
 
a
 
v
 
b
 
3
 
 were ineffective in modulating migration velocity.
Our data demonstrate that cell surface expression of 
 
b
 
1
 
 integrins, although limited on blood
PMNs, is induced in extravasated PMNs, and that members of the 
 
b
 
1
 
 integrin family other
than 
 
a
 
4
 
b
 
1
 
 and 
 
a
 
5
 
b
 
1
 
 are critically involved in the chemokinetic movement of PMNs in rat ex-
travascular tissue in vivo.
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T
 
issue recruitment of circulating leukocytes is a central
event in the host defense against infectious and nox-
ious agents. The extravasation process comprises a multistep
reaction accomplished through a sequential interaction with
vascular endothelium and extravascular matrix components.
The initial steps in this process, i.e., rolling along the endo-
thelium and firm adhesion, have been extensively studied
both in vitro and in vivo, revealing the function of specific
cell adhesion molecules of the selectin and integrin families
(1). In contrast, the subsequent event of leukocyte migra-
tion in the extravascular tissue in response to a chemotactic
stimulus is not well characterized, and the receptor interac-
tions involved in this process are largely unknown.
Several cell surface receptors found on leukocytes recog-
nize and bind extracellular matrix (ECM) components. For
example, all known members of the 
 
b
 
1
 
 integrin (VLA, very
late activation antigen) family bind to ECM proteins with
varying affinity for specific ECM components, e.g., fibro-
nectin, collagen, and laminin (2–5). Although 
 
b
 
1
 
 integrins
have a widespread distribution, the expression on leuko-
cytes has repeatedly been shown to be largely restricted to
eosinophils, monocytes, and certain lymphocyte subsets,
whereas expression on PMNs is limited (2). However, this
view has been reconsidered in recent years because of data
showing that activated or extravasated neutrophils may in-
deed express certain 
 
b
 
1
 
 integrins that potentially can medi-
ate binding to ECM proteins (6–8).
The 
 
b
 
2
 
 integrins (CD11a–c/CD18) are expressed exclu-
sively on leukocytes and mediate firm adhesion to vascular
endothelium (9). Specific ligand binding has been shown for
fibrinogen and factor X of the coagulation cascade, comple-
ment factor C3bi, and intercellular adhesion molecule
(ICAM) 1 (1). Moreover, binding of PMNs to a variety of
biological substrates (e.g., fibronectin, collagen) and nonbio-
logical surfaces (such as plastic) has been reported to be 
 
b
 
2
 
dependent, inasmuch as adhesion can be abrogated by
CD11/CD18-blocking antibodies. Yet another member of
the integrin family that has been demonstrated to bind ECM
components and that is expressed in PMNs is the 
 
a
 
v
 
b
 
3
 
 inte-
grin, which binds to vitronectin and fibronectin (10).
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The aim of this study was to investigate the role of major
integrin receptors in PMN interstitial migration in vivo. The
potential involvement of the fibronectin-binding integrin re-
ceptors in this process was of particular interest because of
their previously documented roles in migration of various cell
types (11–13). An intravital microscopy model was used for
analyzing leukocyte locomotion in response to local chemo-
tactic stimulation in extravascular tissue of the rat mesentery.
Immunofluorescence flow cytometry revealed increased ex-
pression of integrins in extravasated PMNs. This included 
 
b
 
1
 
integrins, which were shown by antibody-blocking experi-
ments to be critically involved in the extravascular PMN mi-
gration. However, this process does not seem to engage the
fibronectin-binding receptors 
 
a
 
4
 
b
 
1
 
 and 
 
a
 
5
 
b
 
1
 
.
 
Materials and Methods
 
Surgical Preparation.
 
Wistar rats of either sex, weighing 200–250
g, were used in the experiments. Anesthesia was induced with equal
parts of fluanison/fentanyl (10/0.2 mg/ml; Hypnorm; Janssen-Cilag
Ltd., Saunderton, UK) and midazolam (5 mg/ml; Dormicum;
Hoffman-La Roche, Basel, Switzerland) diluted 1:1 with sterile wa-
ter (2 mg/kg intramuscularly). Body temperature was maintained at
37
 
8
 
C by a heating pad connected to a rectal thermistor. Laparotomy
was performed, and a segment of the ileum was pulled outside the
peritoneal cavity and placed on a heated transparent pedestal to al-
low microscopic observation of the mesenteric microvasculature.
The exposed tissue was superfused with a warmed (37
 
8
 
C) bicarbon-
ate buffer solution equilibrated with 5% CO
 
2
 
 in N
 
2
 
 to maintain
physiological pH. The experiments were approved by the regional
ethical committee for animal experimentation.
 
Intravital Microscopy.
 
The exposed rat mesentery was observed
through a microscope (Orthoplan; Leitz, Wetzler, Germany)
equipped with a water immersion lens (SW 
 
3
 
 25, NA 0.60; Leitz).
The microscopic image was televised (WV 1050 E/C; Panasonic,
Osaka, Japan) and recorded on time lapse video (AG-6010; Pana-
sonic) connected to a time/date generator (WJ-810; Panasonic).
Recordings were made at one-seventh normal speed. Analysis of
leukocyte migration in the mesenteric tissue was made off-line
from the recorded video scenes during playback at normal speed.
The migration path of individual leukocytes was drawn on a trans-
parent film placed in front of the monitor for subsequent analysis
with a digital image analyzer.
 
Experimental Procedure.
 
After positioning under the micro-
scope, the exposed mesentery was soaked with 5 ml of buffer so-
lution (37
 
8
 
C) containing platelet-activating factor (PAF; Sigma
Chemical Co., St. Louis, MO) at a concentration of 10
 
2
 
7
 
 M. The
tissue was then covered with a transparent plastic film to provide
continuous chemotactic stimulation by PAF. The top of the plas-
tic film was continuously bathed with buffer to maintain temper-
ature at 37
 
8
 
C. After 40 min of chemotactic stimulation, when
numerous leukocytes had extravasated, time-lapse recording of
leukocyte migration was undertaken, first for 20 min to assess
basal migration rates in response to PAF stimulation and then for
an additional 40 min in the presence of PAF and antibodies or
peptides administered to the tissue at a concentration of 100 
 
m
 
g/
ml and 500 mM, respectively. A total of five different fields were
analyzed from each animal. In each field, a minimum of five cells
were selected at random and followed as long as they remained
within the field of observation (at least 2 min). Cells that did not
move during the observation time were not included in the analysis.
 
Antibody Diffusion in the Mesentery.
 
In separate experiments, the
diffusion capability of the Ig molecules in the mesentery was con-
firmed. Pieces of intact mesenteric tissue (thickness: 20–40 
 
m
 
m)
were mounted on plastic rings and placed on top of HBSS-filled
wells (400 
 
m
 
l/well) of a 96-well tissue culture plate. 40 
 
m
 
l of
FITC-conjugated murine IgG (100 
 
m
 
g/ml) were placed on the
surface of the mesentery. The plate was incubated at 37
 
8
 
C for 10
min, and the fluorescence intensity of the IgG content in the up-
per and lower fluid compartments was measured in a fluorometer
(Fluoroscan II; Labsystems Oy, Helsinki, Finland). Over a period
of 10 min, an average of 7.5 
 
6
 
 1.6% of applied antibody diffused
through the mesentery per minute and cm
 
2
 
 (
 
n
 
 
 
5
 
 3), indicating
that there is no significant restriction for diffusion of the antibod-
ies into the mesenteric tissue when being topically administered.
 
Staining of Leukocytes.
 
Representative samples of the mesen-
tery stimulated with PAF 10
 
2
 
7
 
 M for 1.5 h were stained with
Wright/Giemsa (Sigma Chemical Co.) for 10 min in stock con-
centration and in dilution 1:1 with water for another 10 min at
room temperature. Leukocytes in peripheral blood and in perito-
neal fluid collected after 1.5 h PAF stimulation were similarly
stained. After a thorough rinse of the specimens in HBSS, a dif-
ferential leukocyte count was made with an 
 
3
 
100 oil-immersion
objective. In addition to the Wright/Giemsa stain, leukocytes in
the mesenteric tissue were stained by brief exposure to acridine
orange (2.5 mg/ml; Sigma Chemical Co.) and viewed under flu-
orescent light to improve discrimination of nuclear morphology.
Percentage of leukocyte count based on analysis of at least 50 leu-
kocytes in each of 5–7 microscopic fields in each preparation is
given in Table 1 (mean values of data from 3 animals). In another
set of experiments, PAF-stimulated mesenteric tissue was incu-
bated with antibodies against the 
 
b
 
1
 
, 
 
a
 
4
 
, or 
 
b
 
2
 
 integrin subunit for
30 min at 37
 
8
 
C. After washing, the tissue was incubated with
FITC- or TRITC-conjugated F(ab)
 
2
 
 fragments of anti–mouse or
–hamster IgG (diluted 1:50) at room temperature for 30 min. The
tissue was again washed and fixed for 15 min in 4% paraformalde-
hyde. The tissue specimens were observed in normal transmitted
light and with fluorescent epiillumination (filter block I2 and M2;
Leitz Ploemopak). Specificity of antibody binding was confirmed
by comparing the immunofluorescence obtained with specific
primary mAb with that of isotype-matched irrelevant mAb at the
same concentration and incubation time.
 
Immunofluorescence Flow Cytometric Analysis.
 
Leukocytes collected
from rats of the same strain and weight as used in the in vivo exper-
iments were used for analysis of integrin receptor expression. Leu-
 
Table 1.
 
Differential Leukocyte Count (Wright/Giemsa Stain)
 
Percentage of total leukocytes counted
Blood Peritoneal fluid
Mesentery tissue
section
Neutrophils 20.4 
 
6
 
 4.8 69.0 
 
6
 
 12.5 85.7 
 
6
 
 11.8
Eosinophils 1.4 
 
6
 
 0.6 2.8 
 
6
 
 1.2 5.9 
 
6
 
 1.8
Lymphocytes 77.7 
 
6
 
 9.8 1.2 
 
6
 
 0.8 –
Monocytes/ 0.5 
 
6
 
 0.4 27.0 
 
6
 
 7.3 8.4 
 
6
 
 5.8
Macrophages
Mean 
 
6
 
 SD of leukocyte fractions after 1.5 h intraperitoneal stimula-
tion with PAF 10
 
2
 
7
 
 M (
 
n
 
 
 
5
 
 3). 
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kocyte extravasation was induced by intraperitoneal injection of ei-
ther 3% proteose peptone (Sigma Chemical Co.) or PAF 10
 
2
 
7
 
 M
in 10 ml HBSS. After 2 h, the animals were killed with methyl-
ether and peritoneal leukocytes were harvested by washing the
peritoneal cavity with 10 ml ice-cold HBSS. EDTA-anticoagulated
blood was collected from the same animal, and leukocyte-rich
plasma was obtained through dextran sedimentation. Blood and
peritoneal leukocytes were washed twice at 150 g for 7 min at 4
 
8
 
C
and resuspended in HBSS at a final concentration of 10
 
6
 
 cells/ml.
The leukocyte suspension was incubated with primary antibodies
(10 
 
m
 
g/ml) or isotype-matched control antibodies for 20 min at
4
 
8
 
C and washed twice. FITC-conjugated F(ab)
 
2
 
 fragments of rabbit
anti–mouse IgG (Dako, Glostrup, Denmark), donkey anti–rabbit
IgG (Jackson Immunoresearch, West Grove, PA), and goat anti–
hamster IgG (Jackson Immunoresearch) diluted 1:20 were used as
second antibodies. After staining (20 min, 4
 
8
 
C), the cells were fixed
(1% formaldehyde, FACS
 
Ò
 
 Lysing Solution [Becton Dickinson,
Mountain View, CA]), washed twice, and analyzed on a FACSort
 
Ò
 
flow cytometer (Becton Dickinson). The fluorescence intensity of
10
 
4
 
 PMNs (
 
.
 
95% neutrophils; see Table 1) was analyzed by selec-
tive gating based on forward and side scatter parameters.
Antibodies and Peptides. The following antibodies were used:
mAb HMb1-1 (PharMingen, San Diego, CA) and purified IgG
from a rabbit antiserum (gift of K. Rubin, Uppsala, Sweden)
against the rat b1 chain (CD29); mAbs CL26 (Upjohn, Kalama-
zoo, MI) and WT.3 (PharMingen), recognizing the rat b2 chain
(CD18); mAbs MRa4 (PharMingen) and TA-2 (Serotec, Ox-
ford, UK), which react with the rat integrin a4 subunit (CD49d);
mAb HMa5-1 against the rat a5 (CD49e) (PharMingen); and a
rabbit antiserum against human avb3 (CD51/CD61) (14). Func-
tion-blocking activity in rat systems has been documented for all
antibodies used in this study. All antibody solutions were free of
preservatives except MRa4 and HMa5-1, which contained 0.1%
sodium azide. Control experiments showed that sodium azide in
corresponding concentration did not influence cell locomotion.
The integrin-binding peptides SLIDIP and ACRGDGWMCG
(RGDGW), capable of functionally blocking a4b1 and a5b1 (15),
were also used.
Statistical Analysis. Statistical analysis was performed using the
Wilcoxon signed rank test for paired observations. The results are
presented as mean 6 SD for the animals included in each experi-
mental group (n $ 5 unless otherwise stated).
Results
b1-Integrin Cell Surface Expression Is Associated with PMN
Extravasation. Flow cytometric assessment of cell surface
molecule expression on neutrophils that had extravasated
into the peritoneal cavity revealed positive staining for b1
(CD29) and a4 (CD49d) integrin molecules (Fig. 1 and
Table 2). This pattern contrasted to that of blood PMNs
where little or no staining for b1 and a4 was seen (Fig. 1),
indicating that cell surface expression of b1 integrins is in-
duced in conjunction with the extravasation process. Ex-
pression of a5 (CD49e) was limited in both cell popula-
tions. There was an increased expression of b2 integrins
(CD18) on extravasated PMNs compared to their blood
counterpart, whereas staining for avb3 (CD51/CD61) was
similarly positive in both PMN populations (Table 2).
Preincubation of isolated blood PMNs with PAF (1027
M) before antibody labeling did not result in b1 or a4 inte-
grin expression dissimilar from that of untreated blood cells
(data not shown).
PMN Migration In Vivo Is Dependent on b1 Integrins.
Topical stimulation of the rat mesentery with PAF (1027
M) induced profound adhesion and extravasation of circu-
lating leukocytes. At 30–40 min of chemotactic stimula-
tion, numerous leukocytes (predominantly neutrophils, see
Table 1) were migrating further in the extravascular tissue
(Fig. 2 A). In accordance with the flow cytometric data,
immunofluorescent staining of emigrated PMNs in the me-
senteric tissue in situ showed surface expression of b1, a4,
and b2 integrin molecules, as illustrated for a4 in Fig. 2 B.
Fig. 3 A illustrates the frequency distribution of the mi-
gration velocity of individual PMNs in response to stimula-
tion with PAF (649 cells in 30 animals total). Among these
cells, the median migration velocity was 15.5 6 4.5 mm/min
(mean 6 SD). The migration velocity was stable over a pe-
riod of .1.5 h after induction of the chemotactic stimulus.
The role of various integrins in PMN migration was evalu-
ated by topical administration of antibodies to the tissue.
Treatment with anti-b1 (mAb HMb1-1) resulted in a pro-
nounced inhibition of PMN locomotion. Migration ve-
locity was reduced by 67 6 7% (P ,0.01; Fig. 4), yielding
a median migration velocity of 4.6 6 1.3 mm/min (Fig. 3
B). Notably, as evident from Fig. 3 B, the whole popula-
tion of migrating cells, rather than a certain fraction, was
affected by this antibody treatment. A less pronounced ef-
Figure 1. Immunofluorescent
staining of integrins on blood
PMNs (thin line) and on extrava-
sated PMNs collected from the
peritoneal cavity (thick line). Thin
vertical line indicates the 99th
percentile of fluorescence events
for cells stained with isotype
matched control antibody. His-
tograms are representative trac-
ings of three to five analyses for
each antibody.
Table 2. Integrin Expression on Blood and Extravasated rat PMNs
Integrin
Median fluorescence intensity
Blood PMNs Extravasated PMNs
b1 1.9 6 0.6 47.5 6 6.8
b2 15.3 6 3.2 52.5 6 9.5
a4 1.7 6 0.3 16.5 6 3.7
a5 2.2 6 0.9 4.4 6 0.6
avb3 10.0 6 4.3 12.3 6 3.7
Median fluorescence intensity is the staining intensity with specific anti-
body divided by that obtained with control antibody.2094 b1 Integrins Support Neutrophil Locomotion In Vivo
fect was observed with the polyclonal anti-b1 antibody,
which reduced the migration velocity by 32 6 15% (P
,0.01; Fig. 4). No further inhibition was achieved when
the antibody concentration was increased 10-fold. Treat-
ment with two different antibodies against the b2 chain
(CD18) also significantly reduced migration velocity, by 17
6 14% (mAb CL26) and 22 6 13% (mAb WT.3) (P
,0.05; Fig. 4). An additive inhibitory effect was observed
when anti-b2 mAb was administered together with the
polyclonal anti-b1 serum. This combined treatment reduced
migration velocity by 52 6 18% (P ,0.01; Fig. 4). On the
other hand, coadministration of anti-b2 mAb with the anti-b1
mAb HMb1-1 yielded no further inhibition of migration
velocity above that seen with HMb1-1 alone. The inhibi-
tory effect of the various antibody treatments was observed
within minutes after application and persisted throughout the
observation period (.40 min) as shown for mAb HMb1-1
(Fig. 5). Purified hamster, mouse, and rabbit IgG isotype
standards did not influence migration velocity (103 6 11,
95 6 7, and 99 6 8%, respectively).
Despite pronounced upregulation of the integrin a4 sub-
unit (CD49d) on extravasated PMNs, no significant modu-
latory effect on the migration velocity was observed after
treatment with either of the two anti-a4 mAbs. Antibodies
against a5b1 or avb3 also did not influence PMN locomo-
tion. Moreover, combined treatment with anti-b2 mAb to-
gether with either anti-a4 or anti-a4 plus anti-a5 mAb re-
sulted in no further inhibition of migration velocity above
Figure 2. Micrographs showing migrating PMNs in a tissue section of
the rat mesentery after stimulation with PAF (1027 M) for 40 min (A),
and immunofluorescent staining for a4 integrins in the same cells (B). The
fluorescence is concentrated and localized to spots in most PMNs, indi-
cating a polarized integrin expression (arrows), whereas in some cells a
more scattered distribution is seen. Bar: 10 mm.
Figure 3. Frequency distribu-
tion of PMN migration velocity
in extravascular tissue of the rat
mesentery in response to chemo-
tactic stimulation with PAF
(1027 M). (A) Migration veloci-
ties during control period (PAF
alone). (B) Migration velocities
after topical treatment with the
anti-b1 mAb HMb1-1.
Figure 4. Effect of local treatment with various integrin antibodies and
integrin-binding peptides on PMN migration velocity in the rat mesen-
tery stimulated with PAF (1027 M). Data are expressed as percent of mi-
gration velocity before treatment, and represent mean 6 SD of five ex-
periments for each reagent tested. Asterisk, denotes significant difference
from control (P ,0.05).2095 Werr et al. Brief Definitive Report
that obtained with anti-b2 treatment alone (99 6 4 and 95 6
10%, respectively, n 5 3). The integrin-binding peptides
SLIDIP and RGDGW, which mimic natural ligand bind-
ing and block the function of a4b1 and a5b1, respectively,
also had no effect on the migration velocity either in com-
bination (data not shown) or alone (Fig. 4). There was no
difference in the effect for any of the reagents tested when
concentration was raised 10 times (data not shown).
Discussion
Extravasation and tissue accumulation of leukocytes is
one of the key components in the host defense against in-
vading pathogens. After their escape from the blood, the
leukocytes need to migrate in the extravascular tissue, di-
rected by a chemotactic stimulus, to reach the site of injury
or infection. Studies of leukocyte migration in vitro have
indicated the interaction of leukocytic cell surface receptors
with different extracellular matrix components in this pro-
cess (16). However, interactions with the multitudinous
meshwork of biopolymers that characterizes native extracel-
lular matrix and the function in vivo of leukocyte integrins
in the locomotive process have yet to be defined. In this re-
port, we demonstrate that b1 integrins, induced in PMNs in
conjunction with their extravasation, are of critical func-
tional importance for PMN locomotion in extravascular tis-
sue. Our data on a physiological induction of b1 integrin
expression in PMNs agree with recent in vitro and in vivo
findings by Kubes and coworkers (7, 8), and contribute to a
growing body of evidence that b1 integrin expression may
reach significant levels also in neutrophils (6, 17, 18). Also,
the upregulation of b2 integrins on extravasated PMNs is
consistent with the activation-induced upregulation of b2
integrins on the leukocyte surface (19) and the critical role
of this receptor complex in leukocyte adhesion to endothe-
lium and diapedesis through the vessel wall in vivo (20).
A qualitatively similar pattern of PMN b1 integrin ex-
pression as obtained with flow cytometric analysis of ex-
travasated PMNs isolated from the peritoneal cavity could
be demonstrated by in situ immunostaining of PMNs mi-
grating in the extravascular tissue of the mesentery. These
findings are also of significance from a methodological
point of view, since they illustrate that antibodies applied
topically to the mesentery indeed do diffuse into the tissue,
and by this route of administration will reach the migrating
PMNs (see Materials and Methods). Thus, we may con-
clude that adequate antibody concentrations were achieved
in the tissue at the level of the migrating cells (no additional
effect was seen when antibody concentration was raised 10
times), and that restrictions in antibody transport could not
account for the lack of effect of some of the reagents used.
Our quantitative measurements of PMN migration in
the rat mesentery in vivo show that b1 and b2 integrins par-
ticipate in extravascular PMN locomotion, and that they
may cooperate in this process. Blockage of b1 and b2 inte-
grin function impaired the ability of the leukocytes to mi-
grate in the extravascular tissue as indicated by significant
reductions in their migration velocity. Anti-b1 antibodies
were clearly more effective in inhibiting PMN migration
than were anti-b2, suggesting a predominant role of b1 in-
tegrins in the locomotive process in vivo. The additive in-
hibitory effect observed when anti-b2 mAb was coadminis-
tered with the polyclonal anti-b1 antiserum but not when
combined with the anti-b1 mAb may suggest that a syner-
gistic action of combined anti-b1 and anti-b2 treatment is
detectable only when b1 integrins are insufficiently blocked
(as was likely the case when the polyclonal anti-b1 antibody
was used). In contrast to our findings with b2 integrin
blockade, Bienvenu et al. (21), using a similar rat model,
found no inhibition of the extravascular migration with
anti-b2 treatment. Differences in the experimental protocol
(e.g., the antibody concentration used) may explain the dis-
crepant observations. Also, although statistically significant,
the inhibition we found with anti-b2 was limited and may
have been overlooked by these authors.
Although it has been shown for certain leukocyte sub-
types that migration on various ECM matrices in vitro re-
quires the function of specific integrin molecules (16, 22),
this report is the first to demonstrate an in vivo role for b1
integrins in the extravascular locomotion of leukocytes.
Even if it can not be deduced which b1 integrins are pre-
dominantly involved in the PMN locomotion, our data
suggest, based on use of both monoclonal function-block-
ing antibodies and integrin-binding peptides, that the fi-
bronectin binding receptors a4b1 and a5b1 do not partici-
pate in this process. This finding may seem surprising in
light of the pronounced upregulation of a4 integrins on ex-
travasated PMNs, and the central position being attributed
to fibronectin in various aspects of cell migration (11, 12).
Previous findings have suggested a role for a4b1 and a5b1
in migration of PMN from blood to tissue sites in vivo (17)
or through fibroblast monolayers in vitro (18), seemingly in
disparity with our direct observations in the rat mesentery.
Possibly, mAb inhibition of integrin function in these stud-
ies interfered mainly with initial adhesion to endothelium
or the fibroblast monolayer and less with the locomotive
function. Interestingly, through direct observation of leu-
kocyte migration in three-dimensional gels, an enhanced
lymphocyte migration after anti-a4 mAb treatment (16), and
reduced PMN locomotion after the gel being supplemented
with fibronectin was demonstrated (23). These findings may
suggest that fibronectin-binding integrins (e.g., a4b1 and
Figure 5. Time course of in-
hibitory effect of the anti-b1 mAb
HMb1-1 on PMN migration
velocity in the rat mesentery (d)
compared with control antibody
(s). Data are based on calcula-
tion of mean migration velocity
during defined 10 or 20 min in-
tervals, and presented as means
6 SD of five separate experi-
ments for each antibody. Note that the inhibitory effect on PMN loco-
motion persisted throughout the observation period.2096 b1 Integrins Support Neutrophil Locomotion In Vivo
a5b1) may support anchoring of the leukocytes to the sub-
strate rather than promote their migratory movement.
Taken together, expression of b1 integrins, limited on
blood PMNs, is induced in this cell population in conjunc-
tion with their emigration from blood to tissue. Our data
demonstrate that molecules of this integrin family are criti-
cally involved in PMN locomotion in extravascular tissue
in vivo. Hence, in addition to selectin and b2 integrin
functions determining intravascular adhesive events, cell
surface induction and engagement of b1 integrins is sug-
gested to be yet another important physiological mecha-
nism in the multistep process of PMN recruitment to sites
of injury or infection.
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